New modalities of allergen immunotherapy
Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants a...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2018-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a51a97d1974b4f42842a31f2d626d2f4 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Manish Ramesh |e author |
| 700 | 1 | 0 | |a Merhunisa Karagic |e author |
| 245 | 0 | 0 | |a New modalities of allergen immunotherapy |
| 260 | |b Taylor & Francis Group, |c 2018-12-01T00:00:00Z. | ||
| 500 | |a 2164-5515 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 10.1080/21645515.2018.1502126 | ||
| 520 | |a Allergen immunotherapy is a rapidly evolving field. Although subcutaneous immunotherapy has been practiced for over a hundred years, improved understanding of the underlying immunological mechanisms has led to the development of new, efficacious and better tolerated allergen-derivatives, adjuvants and encapsulated allergens. Diverse routes of allergen immunotherapy - oral, sublingual, epicutanoeus and intralymphatic - are enabling immunotherapy for anaphylactic food allergies and pollen-food allergy syndrome, while improving the tolerability and effectiveness of aeroallergen immunotherapy. The addition of Anti-IgE therapy decreases adverse effects of subcutaneous and oral immunotherapy. | ||
| 546 | |a EN | ||
| 690 | |a allergen immunotherapy | ||
| 690 | |a oral immunotherapy | ||
| 690 | |a subcutaneous immunotherapy | ||
| 690 | |a sublingual immunotherapy | ||
| 690 | |a epicutaneous immunotherapy | ||
| 690 | |a adjuvants | ||
| 690 | |a anti-ige | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 2848-2863 (2018) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/21645515.2018.1502126 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/a51a97d1974b4f42842a31f2d626d2f4 |z Connect to this object online. |